Table 3 Comparison of number of hip fractures (n) during exposed and unexposed person-time^a (SIR, 95 % CI)

Thiazide

550

0.7 (0.6–0.7)

441

0.7 (0.6–0.8)

109

0.6 (0.5–0.8)

61

0.7 (0.5–0.8)

208

0.6 (0.6–0.7)

258

0.7 (0.6–0.8)

23

0.8 (0.5–1.2)

–0.6

Loop diuretic

4752

1.0 (1.0–1.0)

3422

1.0 (0.9–1.0)

1330

1.1 (1.1–1.2)

371

2.0 (1.8–2.3)

1538

1.3 (1.2–1.3)

2543

0.9 (0.8–0.9)

300

0.7 (0.6–0.8)

0.1

Beta blocker

4074

0.7 (0.7–0.8)

3010

0.8 (0.8–0.8)

1064

0.7 (0.6–0.7)

511

0.9 (0.9–1.0)

1700

0.8 (0.8–0.8)

1757

0.7 (0.6–0.7)

106

0.6 (0.5–0.8)

–3.5

Calcium channel blocker

5028

0.8 (0.8–0.8)

3736

0.8 (0.8–0.8)

1292

0.7 (0.7–0.8)

642

1.0 (0.9–1.1)

1982

0.8 (0.8–0.8)

2234

0.7 (0.7–0.8)

170

0.7 (0.6–0.8)

–3.4

ACE inhibitor

3438

0.9 (0.9–1.0)

2351

1.0 (0.9–1.0)

1087

0.9 (0.8–0.9)

410

1.3 (1.1–1.4)

1389

1.1 (1.0–1.1)

1512

0.8 (0.8–0.8)

127

0.7 (0.6–0.9)

–0.6

ACE inhibitor/Thiazide

662

0.7 (0.6–0.7)

520

0.7 (0.6–0.8)

142

0.5 (0.4–0.6)

111

1.9 (0.8–1.2)

264

0.7 (0.6–0.7)

261

0.6 (0.5–0.6)

26

0.9 (0.6–1.3)

–0.9

Angiotensin II receptor blocker

2631

0.8 (0.7–0.8)

2041

0.8 (0.8–0.8)

590

0.7 (0.6–0.7)

411

0.9 (0.8–1.0)

1049

0.7 (0.7–0.8)

1094

0.8 (0.7–0.8)

77

0.8 (0.6–1.0)

–1.9

Angiotensin II receptor blocker/Thiazide

2122

0.6 (0.6–0.6)

1688

0.6 (0.6–0.7)

434

0.5 (0.4–0.5)

367

0.7 (0.6–0.7)

915

0.6 (0.6–0.6)

790

0.6 (0.5–0.6)

50

0.6 (0.5–0.9)

–3.6